Medical device stocks

The best medical device stocks depend on your portfolio and investment goals — while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.

Take a deeper dive into medical device stocks

We round up a selection of stocks in or related to the health product industry, weighting the list more heavily towards popular mid- and large-cap US stocks.

---

1. Abbott Laboratories (ABT)

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

Abbott Laboratories stock opened the day at $128.88 after a previous close of $128.38. The latest price was $130.27 (25 minute delay). Abbott Laboratories is listed on the NYSE, has a trailing 12-month revenue of around USD42.3 billion and employs 109,000 staff.

• Market capitalization: $227,012,681,080
• P/E ratio: 32.3251
• PEG ratio: 2.5029

Back to top

---

2. Abiomed (ABMD)

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients.

Abiomed stock opened the day at $338.52 after a previous close of $337.78. The latest price was $325.98 (25 minute delay). Abiomed is listed on the NASDAQ, has a trailing 12-month revenue of around USD$973.6 million and employs 1,725 staff.

• Market capitalization: $13,909,037,667
• P/E ratio: 92.3027
• PEG ratio: 2.75

Back to top

---

3. Align Technology (ALGN)

Align Technology, Inc. , a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services.

Align Technology stock opened the day at $629.36 after a previous close of $624.93. The latest price was $619.75 (25 minute delay). Align Technology is listed on the NASDAQ, has a trailing 12-month revenue of around USD$3.8 billion and employs 21,590 staff.

• Market capitalization: $48,221,017,285
• P/E ratio: 66.7978
• PEG ratio: 3.7789

Back to top

---

4. Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery.

Edwards Lifesciences Corporation stock opened the day at $110.69 after a previous close of $109.82. The latest price was $108.48 (25 minute delay). Edwards Lifesciences Corporation is listed on the NYSE, has a trailing 12-month revenue of around USD$5.1 billion and employs 14,900 staff.

• Market capitalization: $67,727,806,126
• P/E ratio: 46.6581
• PEG ratio: 2.3403

Back to top

---

5. Boston Scientific Corporation (BSX)

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems.

Boston Scientific Corporation stock opened the day at $39.83 after a previous close of $39.60. The latest price was $39.46 (25 minute delay). Boston Scientific Corporation is listed on the NYSE, has a trailing 12-month revenue of around USD$11.5 billion and employs 38,000 staff.

• Market capitalization: $56,230,203,142
• P/E ratio: 51.3134
• PEG ratio: 1.4542

Back to top

---

6. Medtronic (MDT)

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software.

Medtronic stock opened the day at $117.94 after a previous close of $117.67. The latest price was $117.22 (25 minute delay). Medtronic is listed on the NYSE, has a trailing 12-month revenue of around USD$31.8 billion and employs 90,000 staff.

• Market capitalization: $143,496,750,752
• P/E ratio: 30.816
• PEG ratio: 1.9814

Back to top

---

7. Penumbra (PEN)

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands.

Penumbra stock opened the day at $273.78 after a previous close of $273.20. The latest price was $276.55 (25 minute delay). Penumbra is listed on the NYSE, has a trailing 12-month revenue of around USD$710.5 million and employs 3,300 staff.

• Market capitalization: $9,345,677,312
• P/E ratio: 277.9556
• PEG ratio: -62.27

Back to top

---

8. Inogen (INGN)

Inogen, Inc. , a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

Inogen stock opened the day at $66.22 after a previous close of $66.50. The latest price was $66.35 (25 minute delay). Inogen is listed on the NASDAQ, has a trailing 12-month revenue of around USD$355.6 million and employs 938 staff.

• Market capitalization: $724,444,288
• P/E ratio: 63.3797
• PEG ratio: 3.48

Back to top

---

9. SmileDirectClub (SDC)

SmileDirectClub, Inc. operates as an oral care company. It offers clear aligner therapy treatment.

SmileDirectClub stock opened the day at $7.80 after a previous close of $7.60. The latest price was $7.82 (25 minute delay). SmileDirectClub is listed on the NASDAQ, has a trailing 12-month revenue of around USD$695.9 million and employs 4,000 staff.

• Market capitalization: $372,893,595

Back to top

Compare trading platforms

Compare online trading platforms by fees, asset types and bonuses to find the best for your investment in medical device stocks.

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Bottom line

While it’s possible to turn a profit investing in medical device stocks, keep in mind that — like any investment — medical device stocks are not immune to risk. These stocks are subject to fluctuating conditions — both in the market and in the health product industry, so carefully vet your picks before you invest. And if you’re new to investing, or if it’s been awhile since you’ve taken a critical look at your investing accounts, compare brokers to make sure you’re getting the best features in your trading account.